Target intelligence / Profile preview

Conserved multi-epitope regions across coronaviruses

Molecular classification
Viral antigen, Epitope, Structural protein, Non-structural protein
01

Overview

Conserved multi-epitope regions across coronaviruses refer to specific antigenic sequences within viral proteins that remain largely unchanged across different species and variants of the Coronaviridae family. These regions are typically found in functionally critical areas such as the S2 subunit of the Spike protein (including the fusion peptide and stem helix), the Nucleocapsid (N), Membrane (M), and Envelope (E) proteins, as well as non-structural proteins like ORF1ab. Because these sequences are essential for viral replication, assembly, or entry, they are under strong negative selective pressure and are less likely to mutate compared to immunodominant regions like the Receptor Binding Domain (RBD). Consequently, they serve as primary targets for the development of pan-coronavirus vaccines and broadly neutralizing antibodies intended to provide cross-protection against diverse strains, including SARS-CoV-2 variants, SARS-CoV, and MERS-CoV. Therapeutic strategies focusing on these epitopes aim to induce both robust B-cell-mediated humoral immunity and long-lasting T-cell-mediated cellular responses. By targeting these 'Achilles' heels' of the virus, researchers hope to create universal countermeasures that are resilient to viral evolution and future zoonotic spillover events.

Other names
Pan-coronavirus conserved epitopesCross-reactive coronavirus epitopesConserved antigenic regionsMultitope vaccine targetsUniversal coronavirus epitopes
02

Mechanism of action

Induction of broadly neutralizing antibodies and cross-reactive CD4+ and CD8+ T-cell responses to inhibit viral entry, fusion, and replication across multiple coronavirus strains.

03

Biological functions

Viral entryViral membrane fusionViral assemblyGenome packagingViral replication
04

Disease associations

InfectionCOVID-19Severe Acute Respiratory Syndrome (SARS)Middle East Respiratory Syndrome (MERS)
05

Safety considerations

Antibody-dependent enhancement (ADE)Immune imprinting (Original Antigenic Sin)Low immunogenicity of conserved regionsPotential for autoimmune cross-reactivity
06

Interacting drugs

UB-612

4 more in the full profile.

07

Biomarkers

Neutralizing antibody titers (VNT50)Interferon-gamma (IFN-gamma) productionCD8+ T-cell activation (CD107a/Granzyme B)B-cell memory response

Beyond the preview

Go deeper on Conserved multi-epitope regions across coronaviruses.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Conserved multi-epitope regions across coronaviruses.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call